Immunohistochemical analysis of bilateral breast carcinomas: tendency to concordance of ER, PgR and erbB2/HER2 status

被引:0
|
作者
Suspitsin, E.
Giercksky, H.
Lazareva, Y.
Matsko, D.
Borresen-Dale, A.-L.
Imyanitov, E.
机构
[1] NN Petrov Inst Oncol, Grp Mol Diagnost, St Petersburg, Russia
[2] Norwegian Radium Hosp, Oslo, Norway
来源
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:81 / 81
页数:1
相关论文
共 50 条
  • [1] ERBB2 (HER2) Testing in Breast Cancer
    Hilal, Talal
    Romond, Edward H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (12): : 1280 - 1281
  • [2] Correlation of ER (ESR1), PR (PGR), and HER2 (ERBB2) at protein and mRNA levels in operable breast cancer
    Lei, Lei
    Wang, Xiaojia
    Cheng, Skye Hung-Chun
    CANCER RESEARCH, 2022, 82 (04)
  • [3] HER2/ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors
    Smithgall, Marie C.
    Yemelyanova, Anna
    Mathew, Susan
    Gogineni, Swarna
    He, Bing
    Zhang, Taotao
    Robinson, Brian D.
    Tu, Jiangling J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2024, 43 (02) : 134 - 139
  • [4] Immunohistochemical Profile of Breast Cancer with Respect to ER and HER2 Status
    Gloyeske, N. C.
    Yu, J.
    Elishaev, E.
    Woodard, A. H.
    Dabbs, D. J.
    Bhargava, R.
    MODERN PATHOLOGY, 2013, 26 : 44A - 44A
  • [5] Immunohistochemical Profile of Breast Cancer with Respect to ER and HER2 Status
    Gloyeske, N. C.
    Yu, J.
    Elishaev, E.
    Woodard, A. H.
    Dabbs, D. J.
    Bhargava, R.
    LABORATORY INVESTIGATION, 2013, 93 : 44A - 44A
  • [6] ERBB2 (HER2) gene amplification concordance analysis of circulating tumor cells and tumor tissue in patients with breast cancer
    Yeung, Kay T.
    Wang, Yipeng
    Jones, Stephenie
    Brandt, Christopher
    Muller-Cohn, Judy
    Muller, Rolf
    Dickerson, Janet
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Treatment options in ErbB2 (HER2)-overexpressing breast cancer
    Jackisch, Christian
    BREAST CARE, 2008, 3 : 1 - 1
  • [8] Challenges in the treatment of ErbB2 (HER2)-positiive breast cancer
    Jackisch, Christian
    EJC SUPPLEMENTS, 2008, 6 (05): : 7 - 14
  • [9] Changing ER, PgR, and HER2 status between primary and recurrent breast cancer.
    Matsumoto, Akiko
    Takahashi, Maiko
    Hayashida, Tetsu
    Hirose, Shigemichi
    Jinno, Hiromitsu
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [10] Analysis of 47 Patients with Triple Negative (ER, PGR, HER2) Breast Cancer
    Gunes, Mehmet Emin
    Celik, Gurhan
    Trabulus, Fadime Didem
    Aksoy, Sefika
    Ozoran, Emre
    Aren, Acar
    Gucin, Zuhal
    Bahadir, Fadime
    ISTANBUL MEDICAL JOURNAL, 2012, 13 (04): : 166 - 168